JP3131948B2 - Peritoneal dialysis machine - Google Patents
Peritoneal dialysis machineInfo
- Publication number
- JP3131948B2 JP3131948B2 JP03125484A JP12548491A JP3131948B2 JP 3131948 B2 JP3131948 B2 JP 3131948B2 JP 03125484 A JP03125484 A JP 03125484A JP 12548491 A JP12548491 A JP 12548491A JP 3131948 B2 JP3131948 B2 JP 3131948B2
- Authority
- JP
- Japan
- Prior art keywords
- dialysate
- peritoneal
- cavity
- peritoneal dialysis
- intraperitoneal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- External Artificial Organs (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は腹膜透析装置に関し、更
に詳しくは夜間の休眠中、または在宅において腹膜での
透析液の注入および排液を同時に連続的に行うことがで
きる腹膜透析装置に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a peritoneal dialysis device, and more particularly to a peritoneal dialysis device capable of simultaneously and continuously injecting and draining a dialysate in the peritoneum at night or at home.
【0002】[0002]
【従来の技術】連続的人工腎の治療として、連続的腹膜
透析(CAPD)や急性腎不全患者等を対象にした連続的血液
濾過(CHF)等が知られている。それらの1日の低分子量物
質、たとえば尿素のクリアランスは、CAPDの場合、1日
に2リットルの透析液を4回交換し除水量を薬液2リット
ルとしても最大10リットル/日である。また置換液を使
用したCHFでは尿素の血中濃度を100mg/dl以下に維持す
るに必要な置換液量は最低10リットル/日必要である。
更に、間歇的治療である血液透析(HD)においては、血液
尿素窒素(BUN)のクリアランスを150ml/分とし、週3
回、1日4時間透析した時の1週間の累積クリアランスか
ら1日当たりのクリアランスを算出すると15.4リットル
/日に相当するようになる。2. Description of the Related Art Continuous peritoneal dialysis (CAPD), continuous hemofiltration (CHF) for patients with acute renal failure and the like are known as treatments for continuous artificial kidneys. In the case of CAPD, the daily clearance of low molecular weight substances such as urea is up to 10 liters / day, even if 2 liters of dialysate are exchanged four times a day and the amount of water removed is 2 liters of drug solution. In CHF using a replacement solution, the amount of the replacement solution required to maintain the blood concentration of urea at 100 mg / dl or less is at least 10 liters / day.
Furthermore, in hemodialysis (HD), which is an intermittent treatment, the blood urea nitrogen (BUN) clearance was set to 150 ml / min,
When the daily clearance is calculated from the accumulated clearance for one week when dialysis is performed for 4 hours a day, it becomes 15.4 liters / day.
【0003】すなわち現行の人工腎の性能はせいぜい10
〜15リットル/日で生体腎の尿素の1日当たりのクリア
ランスといわれている薬液170リットル/日に遠く及ば
ない。そして、これは片腎廃絶、残り片腎の4/5以上が
機能停止した状態に相当し生体腎の性能に少しでも近づ
く人工腎の開発が要望されてきた。一方、血液透析(HD)
においては図5の1週間3回、1日4時間透析した時の人体
の血液尿素窒素(BUN)の変化を示した図にみられるよう
に、BUN値は大きく変動しており、この変動が全ての合
併症を引き起こす原因になっている。[0003] That is, the performance of the existing artificial kidney is at most 10
It is said to be the daily clearance of urea in living kidney at 1515 liters / day, which is far below 170 liters / day of drug solution. And this corresponds to a state in which one kidney is abolished, and more than 4/5 of the remaining kidneys have stopped functioning, and there has been a demand for the development of artificial kidneys that approach the performance of living kidneys as much as possible. Meanwhile, hemodialysis (HD)
In FIG. 5, as shown in FIG. 5, which shows changes in human blood urea nitrogen (BUN) when dialyzed three times a week for 4 hours a day, the BUN value fluctuates greatly. Causes all complications.
【0004】[0004]
【発明が解決しようとする課題】かかる現行の人工腎の
課題を解決するためには連続的治療による人工腎システ
ムの開発が不可欠である。そのためには昼間患者が活動
しながら人工腎の治療ができ、夜間は休眠しながらでも
透析ができる人工腎の治療が必須の要件である。本発明
者の一人は、かかる課題を解決するために鋭意研究した
結果、昼間は図6に示す連続再循環腹膜透析と濾過器と
を組み合わせた小型で携帯可能な腹膜濾過装置を使用
し、夜間は図7に示す昼間使用した濾過器の濾液側に透
析液を流し透析器として使用することによって、昼夜断
続的に治療を行えることを見出し既に特許出願した(特
願平第2-316652号)。この腹膜透析装置は分離膜からな
る透析器と腹膜透析とを併用して昼夜連続的に血液透析
治療をしているために、尿素の1日当たりのクリアラン
スは現行のHDと比較して大幅に向上し、BUN値の大きな
変動が原因となって起こる種々の合併症も少なくなっ
た。In order to solve the problems of the existing artificial kidney, it is essential to develop an artificial kidney system by continuous treatment. For that purpose, it is essential to treat the artificial kidney while the patient can be active during the day and treat the artificial kidney while sleeping at night. One of the present inventors made extensive study result to solve the above problems, daytime use the portable peritoneal filtration device compact that combines the filter continuous recirculation peritoneal dialysis shown in FIG. 6, It has been found that a treatment can be carried out intermittently during the night by passing a dialysate on the filtrate side of the filter used during the day shown in FIG. 7 and using the dialyser as a dialyzer, and a patent application has already been filed (Japanese Patent Application No. 2-316652). ). This peritoneal dialysis machine uses a dialyzer consisting of a separation membrane and peritoneal dialysis for continuous hemodialysis treatment day and night, so the daily clearance of urea is significantly improved compared to current HD However, various complications caused by large fluctuations in BUN value were also reduced.
【0005】しかしながら、この透析装置は分離膜から
なる透析器を併用しているために血液透析の拡散効率が
低下し、血液中の尿素やβ2-ミクログロブリンのクリア
ランスが低くなる問題があった。本発明の目的は腹腔へ
の透析液の注入と腹腔内透析液の排出とを同時に連続的
に行うことによって、透析効率の高い人工腎治療ができ
る装置を提供することである。However, since this dialysis apparatus uses a dialyzer comprising a separation membrane, the diffusion efficiency of hemodialysis is reduced, and the clearance of urea and β 2 -microglobulin in blood is reduced. . An object of the present invention is to provide an apparatus capable of performing artificial kidney treatment with high dialysis efficiency by simultaneously injecting dialysate into the peritoneal cavity and simultaneously discharging dialysate in the peritoneal cavity.
【0006】[0006]
【課題を解決するための手段】すなわち、本発明は透析
液を貯留する容器と、該容器内の透析液を腹腔へ注入す
るための流入導管と、腹腔内に常時挿入されるカテーテ
ルと、腹腔内透析液を腹腔から取り出すための流出導管
と、流入導管または流出導管とカテーテルとを連結する
ための管継手とからなる腹膜透析装置において、前記カ
テーテルの内腔が、流入導管と連結する透析液注入腔部
と、流出導管と連結する腹腔内透析液排出腔部とに分離
されてなり、透析液を貯留する容器、流入導管、カテー
テル、腹腔および流出導管とが結ばれてなる閉回路内
を、透析液が循環する機構を含むことを特徴とする腹膜
透析装置である。That is, the present invention provides dialysis
A container for storing the fluid, an inflow conduit for injecting the dialysate in the container into the peritoneal cavity, a catheter constantly inserted into the peritoneal cavity, an outflow conduit for removing the intraperitoneal dialysate from the peritoneal cavity, and an inflow conduit or in the peritoneal dialysis apparatus comprising a pipe joint for connecting the outflow conduit and the catheter, the lumen of the mosquito <br/> catheters has a dialysate infusion lumen for coupling the inflow conduit, connecting the outflow conduit Ri Na is separated into the intraperitoneal dialysate discharge cavity, the container for storing the dialysate inlet conduit, Kate
In a closed circuit connecting the tel, peritoneal cavity and outflow conduit
Is a peritoneal dialysis device comprising a mechanism for circulating a dialysate.
【0007】[0007]
【作用】本発明は腹腔内に供給された透析液が腹膜を介
して血液と接触し、腹膜が透過膜の作用をして血液中の
代謝生成物が腹腔内に透過されて、腹腔内透析液とな
る。腹腔内透析液はそのまま廃棄されるか、あるいは透
析液貯蔵容器に戻って透析液と混合され腹腔との間を循
環しながら腹膜透析が行われる。本発明は腹腔内に常時
挿入されるカテーテルが透析液流入口と腹腔内透析液流
出口の2つの導口を有する多重管カテーテル、いわゆる
ダブルルーメンカテーテルからなるために腹腔内透析液
を排出しながら同時に透析液を腹腔に注入することがで
き、連続して腹膜透析を行うことができる。そのために
透析液の腹腔での注入と排液とを交互に数回繰り返して
行う従来の腹膜透析と比較してBUN値の変動が少なく、
透析効率も高い。本発明は夜間の休眠中、または在宅に
おいて連続的に行う腹膜透析であり、昼間の活動期間中
は透析液を腹腔内に滞留させて腹膜透析を行う。According to the present invention, the dialysate supplied to the peritoneal cavity contacts the blood through the peritoneum, the peritoneal membrane acts as a permeable membrane, and metabolites in the blood are permeated into the peritoneal cavity. It becomes a liquid. The intraperitoneal dialysate is either discarded as it is, or returned to the dialysate storage container, mixed with the dialysate, and circulated between the peritoneal cavity to perform peritoneal dialysis. The present invention discharges the intraperitoneal dialysate because the catheter that is always inserted into the abdominal cavity consists of a multi-lumen catheter having two ports of a dialysate inlet and an intraperitoneal dialysate outlet, a so-called double lumen catheter. At the same time, the dialysate can be infused into the peritoneal cavity and peritoneal dialysis can be performed continuously. Therefore, the variation of the BUN value is smaller than that of the conventional peritoneal dialysis in which infusion and drainage of the dialysate in the peritoneal cavity are alternately repeated several times,
High dialysis efficiency. The present invention relates to peritoneal dialysis performed continuously at night or at home, and during the daytime activity, the dialysate is retained in the peritoneal cavity to perform peritoneal dialysis.
【0008】[0008]
【実施例】以下実施例により本発明の一例を説明する。
図1は本発明の一例を示すダブルルーメンカテーテルの
使用状態を示す説明図であり、図2は透析液を循環しな
がら腹膜透析を行う場合の説明図であり、図3は新鮮透
析液を腹腔に注入し、腹腔内透析液を排液する腹膜透析
を行う場合の一例を示す説明図であり、図4は新鮮透析
液を腹腔に注入し、腹腔内透析液を排液する腹膜透析を
行う場合の他の実施例を示す説明図であり、図5は間歇
的血液透析を一週間行った場合のBUNの経時変化を示す
グラフであり、図6は特願平第2-316652号で特許出願し
た昼間活動しながら行う腹膜濾過装置の説明図であり、
図7は特願平第2-316652号で特許出願した夜間の休眠中
に行う腹膜透析装置の説明図である。DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to an embodiment.
FIG. 1 is an explanatory view showing a use state of a double lumen catheter showing one example of the present invention, FIG. 2 is an explanatory view of performing peritoneal dialysis while circulating a dialysate, and FIG. FIG. 4 is an explanatory diagram showing an example of performing peritoneal dialysis in which the dialysate is infused into the peritoneal cavity and draining the intraperitoneal dialysate is performed. FIG. 5 is an explanatory diagram showing another example of the case, FIG. 5 is a graph showing the change over time of BUN when intermittent hemodialysis is performed for one week, and FIG. 6 is a patent in Japanese Patent Application No. 2-316652. It is an explanatory diagram of a peritoneal filtration device that performs while applying for daytime,
FIG. 7 is an explanatory view of a peritoneal dialysis apparatus performed during the nighttime dormancy, which was filed in Japanese Patent Application No. 2-316652.
【0009】図中1、21、31および61は腹腔、3は透析
液注入腔部、4は腹腔内透析液排出腔部、7は流入導管、
8は流出導管、9および10は管継手、22、32および62は透
析液貯蔵容器、24は紫外線ランプ、26、33および63は加
温器、27、49および64は除菌フィルター、28、50および
67は濁度センサー、30、52および66はダブルルーメンカ
テーテルを示す。In the figure, 1, 21, 31 and 61 are abdominal cavities, 3 is a dialysate injecting cavity, 4 is an intraperitoneal dialysate outlet, 7 is an inflow conduit,
8 is an outflow conduit, 9 and 10 are fittings, 22, 32 and 62 are dialysate storage containers, 24 is an ultraviolet lamp, 26, 33 and 63 are warmers, 27, 49 and 64 are sterilization filters, 28, 50 and
67 indicates a turbidity sensor, and 30, 52 and 66 indicate double lumen catheters.
【0010】図1はダブルルーメンカテーテルの使用状
態を示す説明図である。ダブルルーメンカテーテルは外
管とこの管内を挿通する内管とからなり、外管挿外の内
管と外管の管壁に設けられた複数個の穿孔から液体の注
入および排出が行われる構造をしている。ダブルルーメ
ンカテーテルは表皮2から腹腔1内に外管および内管の先
端部が挿入され、常時体内に植え込まれた状態になって
いる。腹腔内のダブルルーメンカテーテルの内管の管壁
には少なくとも1個の透析液注入孔5、また外管の管壁に
は少なくとも1個の腹腔内透析液の排液孔6が複数個穿孔
されて設けられている。ダブルルーメンカテーテルの他
端は外管を挿通して外部に顕出した内管および外管とが
開口してあり、その先端には管継手である流入部コネク
ター10および流出部コネクター9が設けられ、夫々流入
導管7および流出導管8が嵌着されている。流入部コネク
ター10は内管の開口端の外壁面に捻子山を設け、流入導
管7の内腔を嵌着したものであり、流出部コネクター9は
外管の開口端の内腔に外面が捻子山構造をした継手が挿
入され、内管の開口端から突出した継手部に流出導管8
の内腔が嵌着されるようになっている。流出部コネクタ
ー9および流入部コネクター10は昼間の活動期にはキャ
ップ等で嵌着されて閉鎖されている。このようなキャッ
プとしては実開昭第64-19445号公報に記載されているよ
うなキャップが確固に嵌着されて好ましい。FIG. 1 is an explanatory view showing a use state of a double lumen catheter. The double-lumen catheter has an outer tube and an inner tube penetrating the inside of the tube, and has a structure in which liquid is injected and discharged from a plurality of perforations provided in the inner wall of the outer tube and the outer tube wall. are doing. In the double lumen catheter, the distal ends of the outer tube and the inner tube are inserted into the abdominal cavity 1 from the epidermis 2 and are always implanted in the body. At least one dialysate injection hole 5 is formed in the inner wall of the double lumen catheter in the abdominal cavity, and at least one intraperitoneal dialysate drainage hole 6 is formed in the outer tube wall. It is provided. The other end of the double lumen catheter has an inner tube and an outer tube that are exposed to the outside through the outer tube, and an inflow connector 10 and an outflow connector 9 are provided at the ends thereof. The inflow conduit 7 and the outflow conduit 8 are fitted respectively. The inflow connector 10 is provided with a screw thread on the outer wall surface at the open end of the inner tube, and the inner lumen of the inflow conduit 7 is fitted thereto. A joint with a mountain structure is inserted, and the outflow conduit 8 is inserted into the joint protruding from the open end of the inner pipe.
The inner cavity is fitted. Outlet portion connectors 9 and the inflow portion connector 10 is closed is fitted with a cap or the like in the daytime active phase. As such a cap, a cap described in Japanese Utility Model Laid-Open Publication No. 64-19445 is firmly fitted and is preferable.
【0011】透析液は流入導管7からダブルルーメンカ
テーテルの内管の中空部である注入液腔部3を通り、注
入孔5から腹腔1内に注入される。腹膜(図示せず)を介
して血液と接触し血液中の代謝生成物を透過してなる腹
腔内透析液は排出孔6から外管の中空部である排液腔部4
を通り、流出導管8から廃棄されるかまたは透析液貯蔵
容器に戻り透析液と混合される。透析液の腹腔への注入
と腹腔内透析液の排出は同時に連続して行われるが、必
要により内管の注入液腔部3内に逆止弁を設けて腹腔内
透析液が注入液腔部3へ流入するのを防止する手段を設
けてもよい。図1ではダブルルーメンカテーテルは外管
とこの管内を挿通する内管とからなる構造をしている
が、カテーテルの内腔がシート等で分離されて2室から
なり、その先端付近の側壁には夫々複数個の側孔が設け
られ他端は導管が各室に挿通またはコネクターを介して
嵌着される構造でもよい。The dialysate is injected into the abdominal cavity 1 from the infusion hole 5 through the infusion solution cavity 3 which is the hollow portion of the inner tube of the double lumen catheter. The intraperitoneal dialysate, which is in contact with the blood through the peritoneum (not shown) and permeates the metabolites in the blood, passes through the drain hole 6 to the drain cavity 4 which is the hollow part of the outer tube.
Through the outlet conduit 8 or returned to the dialysate storage container to be mixed with the dialysate. Injection of the dialysate into the peritoneal cavity and discharge of the dialysate in the peritoneal cavity are performed simultaneously and continuously. Means for preventing inflow into 3 may be provided. In FIG. 1, the double-lumen catheter has a structure consisting of an outer tube and an inner tube inserted through this tube, but the lumen of the catheter is separated by a sheet or the like and is composed of two chambers. A plurality of side holes may be provided, and the other end may have a structure in which a conduit is inserted into each chamber or fitted through a connector.
【0012】図2は透析液を循環しながら腹膜透析を行
う場合の腹膜透析の説明図である。透析液貯蔵容器22内
には透析液が貯蔵されており、循環ポンプ23によって腹
腔21から戻ってくる腹腔内透析液と混合されるようにな
っている。貯蔵容器22と循環ポンプ23の循環ラインには
紫外線ランプ24が設けられ、透析液が紫外線によって滅
菌されるようになっている。透析液貯蔵容器22中の透析
液は注入液ポンプ25によってダブルルーメンカテーテル
30の注入液腔部から腹腔21へ供給される。その途中透析
液は加温器26によって加温され、次いで除菌フィルター
27によって細菌が除去され腹腔21内へ細菌が侵入して腹
膜炎を起こすのを防止する。腹腔21内で腹膜を介して血
液中の代謝生成物を透析して得られた腹腔内透析液はダ
ブルルーメンカテーテル30の排液腔部から排液ポンプ29
によって透析液貯蔵容器22に戻り容器22内の透析液と混
合される。その途中、濁度センサー28が設けられ腹腔内
透析液の濁度を測定することによって腹腔内の炎症の発
生等を確認する。図2のような透析液循環方式の腹膜透
析は透析液貯蔵容器22に多量の透析液が貯蔵されて使用
される場合に好ましい。透析液量としては20〜200リッ
トル、好ましくは40〜120リットルである。透析液の腹
腔への供給をダブルルーメンカテーテルを介して注入と
排液を行うと腹膜透析を高い透析効率で行うことができ
る。FIG. 2 is an explanatory diagram of peritoneal dialysis when peritoneal dialysis is performed while circulating a dialysate. The dialysate is stored in the dialysate storage container 22, and is mixed with the intraperitoneal dialysate returned from the abdominal cavity 21 by the circulation pump 23. An ultraviolet lamp 24 is provided in the circulation line of the storage container 22 and the circulation pump 23 so that the dialysate is sterilized by ultraviolet light. The dialysate in the dialysate reservoir 22 is pumped by the infusion pump 25 into a double lumen catheter.
The liquid is supplied to the abdominal cavity 21 from the infused liquid cavity 30. On the way, the dialysate is heated by the heater 26, and then the sterilizing filter
The bacteria are removed by 27 to prevent the bacteria from entering the peritoneal cavity 21 and causing peritonitis. The intraperitoneal dialysate obtained by dialyzing the metabolic product in the blood through the peritoneum in the abdominal cavity 21 is drained from the drainage cavity of the double lumen catheter 30 through the drainage pump 29.
As a result, the liquid returns to the dialysate storage container 22 and is mixed with the dialysate in the container 22. On the way, a turbidity sensor 28 is provided to measure the occurrence of inflammation in the abdominal cavity by measuring the turbidity of the intraperitoneal dialysate. The peritoneal dialysis using the dialysate circulation system as shown in FIG. 2 is preferable when a large amount of dialysate is stored in the dialysate storage container 22 and used. The dialysate volume is 20-200 liters, preferably 40-120 liters. By injecting and draining the dialysate into the peritoneal cavity via a double lumen catheter, peritoneal dialysis can be performed with high dialysis efficiency.
【0013】図3は新鮮透析液をダブルルーメンカテー
テルを介して連続して腹腔へ注入し、同時に腹腔内透析
液を廃棄する腹膜透析の一例を示す説明図である。透析
液貯蔵容器32には新鮮透析液が貯蔵され加温器33で加温
されて等液量ポンプであるベローポンプの第1ベロー部4
5に供給される。ベローポンプは同容量の第1ベロー部45
と第2ベロー部46とがクランクモーター42によって左右
にベロー位置が伸縮する構造をしており、それによって
腹腔31への新鮮透析液の注入量と腹腔内透析液の排液量
をほぼ同等に調節することができる。図3において、第1
ベロー部45と第2ベロー部46がクランクモーター42によ
って左右にベロー位置が伸縮してなる第1ベローポンプ
と、第3ベロー部47と第4ベロー部48がクランクモーター
43によって形成される第2ベローポンプとにより、腹腔3
1への新鮮透析液の供給量と腹腔内透析液の排液量がほ
ぼ等量に調節されるようになっている。FIG. 3 is an explanatory diagram showing an example of peritoneal dialysis in which fresh dialysate is continuously infused into the peritoneal cavity via a double lumen catheter, and simultaneously the dialysate in the peritoneal cavity is discarded. A fresh dialysate is stored in a dialysate storage container 32 and heated by a heater 33 to be a first bellows part 4 of a bellows pump that is an equal volume pump.
Supplied to 5. The bellows pump has the same capacity as the first bellows part 45
And the second bellows portion 46 have a structure in which the bellows position expands and contracts to the left and right by the crank motor 42, whereby the amount of fresh dialysate injected into the peritoneal cavity 31 and the amount of drainage of intraperitoneal dialysate are made substantially equal. Can be adjusted. In FIG. 3, the first
A first bellows pump in which a bellows portion 45 and a second bellows portion 46 are expanded and contracted to the left and right by a crank motor 42, and a third bellows portion 47 and a fourth bellows portion 48 are crank motors.
Abdominal cavity 3 with the second bellows pump formed by 43
The supply amount of fresh dialysate to 1 and the drainage amount of intraperitoneal dialysate are adjusted to be substantially equal.
【0014】図3において、バルブ34〜41の白色で示す3
4、37、38および40は開放状態、黒色で示す35、36、39
および41は閉鎖状態を示す。図3の状態は透析液貯蔵容
器32から新鮮透析液が加温器33によって加温されて第1
ベロー部45に流入され、第2ベロー部46に予め充満され
ていた腹腔内透析液はバルブ40から排液容器51へ廃棄さ
れる。一方、第2ベローポンプでは第3ベロー部47に予め
充満されていた新鮮透析液がバルブ37を経て除菌フィル
ター49で除菌され腹腔31に注入される。腹腔31内の腹腔
内透析液は濁度センサー50で濁度を測定されてバルブ38
を経て第4ベロー部48に流入する。各ベロー部は夫々同
容量であり、一連の操作が終了すると開放状態のバルブ
が閉鎖状態に、閉鎖状態のバルブが開放状態に変わり、
第1ベローポンプと第2ベローポンプの操作が逆になって
同じような操作を行う。In FIG. 3, the bulbs 34 to 41 are shown in white.
4, 37, 38 and 40 are open, shown in black 35, 36, 39
And 41 indicate a closed state. The state of FIG. 3 is warmed by the dialysate reservoir 32 fresh dialysate is warmer 33 from the first
The intraperitoneal dialysate that has flowed into the bellows portion 45 and previously filled in the second bellows portion 46 is discarded from the valve 40 to the drainage container 51. On the other hand, in the second bellows pump, the fresh dialysate previously filled in the third bellows portion 47 is sterilized by the sterilization filter 49 through the valve 37 and injected into the abdominal cavity 31. The dialysate in the abdominal cavity 31 is measured for turbidity by the turbidity sensor 50 and the valve 38
And flows into the fourth bellows section 48. Each bellows part has the same capacity, and when a series of operations is completed, the open valve changes to the closed state, the closed valve changes to the open state,
The same operation is performed by reversing the operations of the first bellows pump and the second bellows pump.
【0015】図4は新鮮透析液をダブルルーメンカテー
テルを介して連続して腹腔へ注入し同時に腹腔内透析液
を廃棄する腹膜透析において、等液量ポンプとして2連
式ローラポンプを使用した場合の説明図である。透析液
貯蔵容器62には新鮮透析液が貯蔵され、加温器63で加温
された後に除菌フィルター64で細菌が除去され、2連式
ローラポンプ65によってダブルルーメンカテーテル66を
経て腹腔61に注入される。2連式ローラポンプは同じ内
径からなる流入導管(チューブ)と流出導管(チュー
ブ)を1つのローラポンプに2本掛けしたポンプであっ
て、チューブ内径が同じであるので腹腔61へ注入される
透析液量と腹腔61から排出される腹腔内透析液量とはほ
ぼ同一に調節される。腹腔61から排出された腹腔内透析
液は濁度センサー67で濁度を測定した後、排液容器68で
廃棄される。FIG. 4 shows a case in which a double roller pump is used as an equal volume pump in peritoneal dialysis in which fresh dialysate is continuously infused into the peritoneal cavity via a double lumen catheter and at the same time the intraperitoneal dialysate is discarded. FIG. Fresh dialysate is stored in the dialysate storage container 62, and after being heated by the heater 63, the bacteria are removed by the sterilization filter 64, and the double-lumen roller pump 65 passes through the double lumen catheter 66 to the abdominal cavity 61. Injected. The double roller pump is a pump in which two inflow conduits (tubes) and two outflow conduits (tubes) having the same inner diameter are hung on one roller pump. Since the inner diameters of the tubes are the same, the dialysis is injected into the abdominal cavity 61. The volume of the fluid and the volume of the intraperitoneal dialysate discharged from the abdominal cavity 61 are adjusted to be substantially the same. The intraperitoneal dialysate discharged from the abdominal cavity 61 is measured in the turbidity sensor 67 and then discarded in the drainage container 68.
【0016】[0016]
【実施例1】図2において、透析液貯蔵容器22に新鮮透
析液50リットルを貯蔵し、加温器26で透析液を体温に加
温し、毎分100mlの速度で腹腔21へ注入し、腹腔内透析
液を同じ速度で腹腔21から排出し透析液貯蔵容器22へ戻
し、容器内の透析液と循環ポンプ23を使用して混合しな
がら腹膜透析を8時間行った。次いで、腹腔内の透析液
を排液バッグに排液した後、別途新鮮透析液2リットル
を腹腔に注入し16時間腹腔内で腹膜透析をした。合計24
時間の腹膜透析で得られた尿素およびβ2-ミクログロブ
リンのクリアランスを表1に示す。Example 1 In FIG. 2, 50 liters of fresh dialysate was stored in a dialysate storage container 22, and the dialysate was heated to body temperature by a heater 26, and injected into the abdominal cavity 21 at a rate of 100 ml per minute. The intraperitoneal dialysate was discharged from the peritoneal cavity 21 at the same speed, returned to the dialysate storage container 22, and peritoneal dialysis was performed for 8 hours while mixing with the dialysate in the container using the circulation pump 23. Next, after the dialysate in the peritoneal cavity was drained into a drain bag, 2 liters of fresh dialysate was separately injected into the peritoneal cavity, and peritoneal dialysis was performed in the peritoneal cavity for 16 hours. Total 24
Table 1 shows the clearance of urea and β 2 -microglobulin obtained by peritoneal dialysis over time.
【0017】[0017]
【実施例2】図4において、新鮮透析液を毎分100mlの速
度で腹腔61へ注入し、腹腔内透析液を同じ速度で腹腔61
から排出し排液容器68へ排液する腹膜透析を8時間行っ
た。次いで新鮮透析液2リットルを腹腔61に注入したま
ま16時間腹腔内で腹膜透析を行った。合計24時間の腹膜
透析で得られた尿素およびβ2-ミクログロブリンのクリ
アランスを表1に示す。Example 2 In FIG. 4, a fresh dialysate was injected into the abdominal cavity 61 at a rate of 100 ml / min, and an intraperitoneal dialysate was injected into the abdominal cavity 61 at the same speed.
Peritoneal dialysis of draining from the drainage container 68 for 8 hours. Next, peritoneal dialysis was performed in the abdominal cavity for 16 hours while 2 liters of the fresh dialysate was injected into the abdominal cavity 61 . Table 1 shows the clearance of urea and β 2 -microglobulin obtained by peritoneal dialysis for a total of 24 hours.
【0018】[0018]
【比較例1】図6の腹膜濾過装置において、腹腔71に2リ
ットルの新鮮透析液を注入した。第1濾過器72の第1濾過
膜74の孔径は14mμで膜面積は0.2m2である。第1濾過器7
2を通過した腹腔内透析液は第2濾過器73の第2濾過液室7
9に供給され、第1濾過器72の第1濾過膜74で濾過された
後第2濾過器73の第2濾過膜75で濾過された濾過液と混合
されて腹腔71へ戻る。この時第2濾過器73の第2供給液室
78から第1濾過器72の第1濾過膜74で濾過された濾過液の
一部が排出導管76を経て排出される。第2濾過膜75の孔
径は3.5mμで膜面積は0.2m2である。循環する透析液流
量は80ml/分で、第1濾過器72の濾液流量は40ml/分、
第2濾過器73の濾液流量は38ml/分、除水流量は2ml/分
で、1日に16時間濾過した。次いで夜間には図7の腹膜透
析装置を使用した。第1透析器81および第2透析器82は昼
間使用した図6の第1濾過器72および第2濾過器73を使用
してサイクラーによる透析に変更した腹膜透析装置であ
る。第1透析器81の濾液側である第1透析液室86と第1透
析液貯蔵容器83との間で処理済透析液が循環する閉回路
を形成する。また第2透析器82の濾液側である第2透析液
室88と第2透析液貯蔵容器84との間でも第2透析膜87を透
過した処理済透析液が循環する閉回路が形成される。腹
腔80から供給された腹腔内透析液は第1透析器81を通過
した後、第2透析器82を通過して腹腔80に戻る閉回路を
循環しながら腹膜透析が行われる。その時の循環透析液
流量は100ml/分、サイクラーの新鮮透析液流量は100ml
/分で8時間透析した。合計24時間の腹膜透析で得られ
た尿素およびβ2-ミクログロブリンのクリアランスを表
1に示す。Comparative Example 1 In the peritoneal filtration apparatus shown in FIG. 6, 2 liters of fresh dialysate was injected into the peritoneal cavity 71. The pore size of the first filtration membrane 74 of the first filter 72 is 14 mμ, and the membrane area is 0.2 m 2 . 1st filter 7
The intraperitoneal dialysate that has passed through 2 flows into the second filtrate chamber 7 of the second filter 73.
9 and filtered by the first filtration membrane 74 of the first filter 72 .
Thereafter, the mixture is mixed with the filtrate filtered by the second filtration membrane 75 of the second filter 73 and returns to the peritoneal cavity 71. At this time, the second supply liquid chamber of the second filter 73
From 78, a part of the filtrate filtered by the first filtration membrane 74 of the first filter 72 is discharged through the discharge conduit 76. The pore size of the second filtration membrane 75 is 3.5 mμ, and the membrane area is 0.2 m 2 . The circulating dialysate flow rate is 80 ml / min, the filtrate flow rate of the first filter 72 is 40 ml / min,
The filtrate in the second filter 73 was at a flow rate of 38 ml / min, and the dewatering flow rate was 2 ml / min. Then, at night, the peritoneal dialysis apparatus of FIG. 7 was used. The first dialyzer 81 and the second dialyzer 82 use the first filter 72 and the second filter 73 of FIG. 6 used during the day.
This is a peritoneal dialysis device that has been changed to dialysis using a cycler. A closed circuit in which the treated dialysate circulates is formed between the first dialysate chamber 86 on the filtrate side of the first dialyzer 81 and the first dialysate storage container 83. Also, a closed circuit is formed between the second dialysate chamber 88 on the filtrate side of the second dialyzer 82 and the second dialysate storage container 84 in which the processed dialysate that has passed through the second dialysate membrane 87 circulates. . After the intraperitoneal dialysate supplied from the abdominal cavity 80 passes through the first dialyzer 81, the peritoneal dialysis is performed while circulating through a closed circuit returning to the abdominal cavity 80 through the second dialyzer 82. The circulating dialysate flow at that time is 100 ml / min, and the fresh dialysate flow of the cycler is 100 ml.
Per minute for 8 hours. Table 1 shows the clearance of urea and β 2 -microglobulin obtained by peritoneal dialysis for a total of 24 hours.
【0019】[0019]
【比較例2】現行の血液透析を血液流量150ml/分、週3
回、1回4時間した時の1週間の累積クリアランスから1日
当たりの尿素およびβ2-ミクログロブリンのクリアラン
スを換算し、その結果を表1に示す。[Comparative Example 2] Current hemodialysis was performed at a blood flow rate of 150 ml / min.
The clearance of urea and β 2 -microglobulin per day was calculated from the cumulative clearance for one week after four hours, once each, and the results are shown in Table 1.
【0020】[0020]
【比較例3】腹腔に新鮮透析液を2リットル注入し6時間
腹膜透析をした。その後、腹腔内透析液を排出し、新鮮
透析液2リットルを腹腔に注入した。この操作を1日4回
繰り返した後の合計24時間の腹膜透析で得られた尿素お
よびβ2-ミクログロブリンのクリアランスを表1に示
す。クリアランスの単位はリットル/日である。Comparative Example 3 Two liters of a fresh dialysate was injected into the peritoneal cavity, and peritoneal dialysis was performed for 6 hours. Thereafter, the intraperitoneal dialysate was drained, and 2 liters of fresh dialysate was injected into the peritoneal cavity. Table 1 shows the clearance of urea and β 2 -microglobulin obtained by peritoneal dialysis for a total of 24 hours after repeating this operation four times a day. The unit of clearance is liter / day.
【0021】[0021]
【表1】 [Table 1]
【0022】表1から明らかなように、本発明の腹膜透
析装置である実施例1および2は現行の血液透析(比較例
2)や腹膜灌流装置(比較例3)と比較して遥かに優れた
透析性能を有している。また分離膜を併用した腹膜透析
装置である比較例1よりも透析効率は高い結果を得た。As apparent from Table 1, Examples 1 and 2, which are the peritoneal dialysis devices of the present invention, are the same as those of the current hemodialysis (Comparative Example).
It has much better dialysis performance than 2) or peritoneal perfusion device (Comparative Example 3). In addition, the dialysis efficiency was higher than that of Comparative Example 1, which was a peritoneal dialysis device combined with a separation membrane.
【0023】[0023]
【発明の効果】本発明は腹腔内に常時挿入されるカテー
テルが透析液流入口と腹腔内透析液流出口の2つの導口
を有する多重管カテーテル、いわゆるダブルルーメンカ
テーテルからなるために腹腔内透析液を排出しながら同
時に透析液を腹腔に注入することができ、連続して腹膜
透析を行うことができる。そのために透析液の腹腔での
注入と排液とを交互に数回繰り返して行う従来の腹膜透
析と比較してBUN値の変動が少なく、透析効率も高い。According to the present invention, since the catheter which is always inserted into the peritoneal cavity is a multi-lumen catheter having two inlets, that is, a dialysate inlet and an intraperitoneal dialysate outlet, a so-called double lumen catheter, the intraperitoneal dialysis is performed. The dialysate can be simultaneously injected into the peritoneal cavity while draining the fluid, and continuous peritoneal dialysis can be performed. Therefore, compared with the conventional peritoneal dialysis in which the infusion of the dialysate in the peritoneal cavity and the drainage are alternately repeated several times, the fluctuation of the BUN value is small and the dialysis efficiency is high.
【図1】本発明の一例を示すダブルル−メンカテ−テル
の使用状態を示す説明図FIG. 1 is an explanatory view showing a state of use of a double lumen catheter showing an example of the present invention.
【図2】本発明の一例を示す透析液を循環しながら腹膜
透析を行う場合の説明図FIG. 2 is an explanatory view showing an example of the present invention when performing peritoneal dialysis while circulating a dialysate.
【図3】新鮮透析液を腹腔に注入し、腹腔内透析液を排
液する腹膜透析を行う場合の一例を示す説明図FIG. 3 is an explanatory view showing an example of performing peritoneal dialysis in which fresh dialysate is injected into the peritoneal cavity and dialysate in the peritoneal cavity is drained.
【図4】新鮮透析液を腹腔に注入し、腹腔内透析液を排
液する腹膜透析を行う場合の他の実施例を示す説明図FIG. 4 is an explanatory diagram showing another example of performing peritoneal dialysis in which fresh dialysate is injected into the peritoneal cavity and the intraperitoneal dialysate is drained.
【図5】間歇的血液透析を一週間行った場合のBUN の経
時変化を示すグラフFIG. 5 is a graph showing the time course of BUN when intermittent hemodialysis is performed for one week.
【図6】特願平第2−316652号で特許出願した昼間活動
しながら行う腹膜濾過装置の説明図FIG. 6 is an explanatory view of a peritoneal filtration apparatus performed during daytime activities, which was filed in Japanese Patent Application No. 2-316652.
【図7】特願平第2-316652号で特許出願した夜間の休眠
中に行う腹膜透析装置の説明図FIG. 7 is an explanatory view of a peritoneal dialysis apparatus performed during nighttime dormancy for which a patent application has been filed in Japanese Patent Application No. 2-316652.
1、21、31、61 腹腔 3 透析液注入腔部 4 腹腔内透析液排出腔部 7 流入導管 8 流出導管 9、10 管継手 22、32、62 透析液貯蔵容器 26、33、63 加温器 27、49、64 除菌フイルタ− 28、50、67 濁度センサ− 30、52、66 ダブルル−メンカテ−テル 1, 21, 31, 61 Abdominal cavity 3 Dialysate infusion cavity 4 Intraperitoneal dialysate discharge cavity 7 Inflow conduit 8 Outflow conduit 9, 10 Fitting 22, 32, 62 Dialysate storage container 26, 33, 63 Heater 27, 49, 64 Bactericidal filter 28, 50, 67 Turbidity sensor 30, 52, 66 Double lumen catheter
Claims (1)
析液を腹腔へ注入するための流入導管と、腹腔内に常時
挿入されるカテーテルと、腹腔内透析液を腹腔から取り
出すための流出導管と、流入導管または流出導管とカテ
ーテルとを連結するための管継手とからなる腹膜透析装
置において、前記カテーテルの内腔が、流入導管と連結
する透析液注入腔部と、流出導管と連結する腹腔内透析
液排出腔部とに分離されてなり、透析液を貯留する容
器、流入導管、カテーテル、腹腔および流出導管とが結
ばれてなる閉回路内を、透析液が循環する機構を含むこ
とを特徴とする腹膜透析装置。 A container for storing a dialysate, an inflow conduit for injecting a permeate into the peritoneal cavity, a catheter constantly inserted into the peritoneal cavity, In a peritoneal dialysis device comprising an outflow conduit for removing from the abdominal cavity and a fitting for connecting the inflow conduit or the outflow conduit to the catheter, the lumen of the catheter has a dialysate infusion portion connected to the inflow conduit. , Ri Na are separated into the intraperitoneal dialysate discharge lumen for connecting the outflow conduit, volume for storing dialysate
Devices, inflow conduits, catheters, peritoneal and outflow conduits
Include a mechanism for circulating dialysate in the closed closed circuit.
A peritoneal dialysis device characterized by the following .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03125484A JP3131948B2 (en) | 1991-04-26 | 1991-04-26 | Peritoneal dialysis machine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03125484A JP3131948B2 (en) | 1991-04-26 | 1991-04-26 | Peritoneal dialysis machine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04327857A JPH04327857A (en) | 1992-11-17 |
JP3131948B2 true JP3131948B2 (en) | 2001-02-05 |
Family
ID=14911235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03125484A Expired - Fee Related JP3131948B2 (en) | 1991-04-26 | 1991-04-26 | Peritoneal dialysis machine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3131948B2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09327511A (en) * | 1996-06-12 | 1997-12-22 | A S A Sangyo Kk | Method for recovering and regenerating peritoneal dialysis liquid and treating device and ancillary appliance for this purpose |
US7510550B2 (en) | 1999-07-19 | 2009-03-31 | I-Flow Corporation | Catheter for uniform delivery of medication |
US7004923B2 (en) | 1999-07-19 | 2006-02-28 | I-Flow Corporation | Catheter for uniform delivery of medication |
US7452353B2 (en) | 1999-07-19 | 2008-11-18 | I-Flow Corporation | Catheter for uniform delivery of medication |
US7547302B2 (en) | 1999-07-19 | 2009-06-16 | I-Flow Corporation | Anti-microbial catheter |
US6350253B1 (en) | 1999-07-19 | 2002-02-26 | I-Flow Corporation | Catheter for uniform delivery of medication |
ATE333915T1 (en) | 2000-03-24 | 2006-08-15 | Stephen Brushey | CONDUCTING CATHETER FOR ANESTHESIA |
JP4826991B2 (en) * | 2001-07-19 | 2011-11-30 | 株式会社ジェイ・エム・エス | Circuit for automatic peritoneal dialysis machine with sanitizing filter |
US8202248B2 (en) | 2004-08-18 | 2012-06-19 | Sequana Medical Ag | Dialysis implant and methods of use |
WO2006022025A1 (en) * | 2004-08-26 | 2006-03-02 | Kobayashi, Hideki | Medical instrument |
WO2012112664A1 (en) | 2011-02-16 | 2012-08-23 | Sequana Medical Ag | Apparatus and methods for treating intracorporeal fluid accumulation |
US8585635B2 (en) | 2012-02-15 | 2013-11-19 | Sequana Medical Ag | Systems and methods for treating chronic liver failure based on peritoneal dialysis |
AU2012369988B2 (en) * | 2012-02-15 | 2017-02-02 | Sequana Medical Nv | Systems and methods for treating chronic liver failure based on peritioneal dialysis |
US10716922B2 (en) | 2016-08-26 | 2020-07-21 | Sequana Medical Nv | Implantable fluid management system having clog resistant catheters, and methods of using same |
AU2017316520A1 (en) | 2016-08-26 | 2019-03-14 | Sequana Medical Nv | Systems and methods for managing and analyzing data generated by an implantable device |
CN111315427B (en) | 2017-05-24 | 2023-04-07 | 塞奎阿纳医疗有限公司 | Direct sodium removal method, solution and device for reducing fluid overload in heart failure patients |
US11559618B2 (en) | 2017-05-24 | 2023-01-24 | Sequana Medical Nv | Formulations and methods for direct sodium removal in patients having severe renal dysfunction |
CN112023163B (en) * | 2020-09-14 | 2023-08-01 | 中国人民解放军联勤保障部队第九〇〇医院 | Peritoneal dialysis tube for nephrology department |
-
1991
- 1991-04-26 JP JP03125484A patent/JP3131948B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH04327857A (en) | 1992-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3131948B2 (en) | Peritoneal dialysis machine | |
JP6921014B2 (en) | Systems and methods for performing peritoneal dialysis | |
US6429294B1 (en) | Peritoneal dialysis fluid and method for a continuous recirculating peritoneal dialysis using the same | |
JP3677045B2 (en) | Apparatus for tidal vibration pulse peritoneal dialysis | |
US6585681B2 (en) | Methods and apparatus for performing flow-through peritoneal dialysis | |
EP0928615A1 (en) | Method for recovering and regenerating peritoneal dialyzate, apparatus therefor, and attachments thereof | |
WO1995035124A1 (en) | Method and apparatus for purified pulse peritoneal dialysis | |
JP2005533574A (en) | System and method for peritoneal dialysis | |
JP3906477B2 (en) | Method for priming blood circuit | |
JP4129726B2 (en) | Peritoneal dialysis machine | |
JP2637621B2 (en) | Peritoneal dialysis machine | |
JP2512628B2 (en) | Peritoneal filtration device | |
JP2002095740A (en) | Method for returning residual blood in blood circuit and device for blood purification | |
JP2003260129A (en) | Hypertonic solution injector | |
JP5995221B6 (en) | System and method for performing peritoneal dialysis | |
JPS5968A (en) | Semi-continuous portable blood dialytic system | |
Gokal | Dialysis techniques: peritoneal dialysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |